aspirin has been researched along with Colitis, Ischemic in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Colitis, Ischemic: Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of low-dose aspirin may aggravate the severity and mask the symptoms of abdominal pain in ischemic colitis." | 3.96 | Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study. ( Deng, B; Ding, Y; Gong, W; Lu, G; Wang, Y; Wu, D; Wu, K; Xiao, W; Zhou, SY, 2020) |
| "96) as well as history of hematemesis, melena in the past 30 days, positive nasogastric aspirate, prior upper gastrointestinal bleeding or use of aspirin or non-steroidal anti-inflammatory." | 3.83 | Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics. ( Camus, M; Dulai, GS; Ghassemi, KA; Jensen, DM; Jutabha, R; Khungar, V; Kovacs, TO; Machicado, GA; Ohning, GV, 2016) |
| "Chronic constipation, enteric-coated aspirin intake and splanchnic atherosclerosis are risk factors related to ulcer in IC patients." | 3.80 | [An analysis of clinical characteristics and risk factors for ulceration in ischemic colitis]. ( Li, X; Liao, L; Liu, W; Liu, Y; Shi, H; Wu, B, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, W | 1 |
| Zhou, SY | 1 |
| Wu, K | 1 |
| Deng, B | 1 |
| Wu, D | 1 |
| Wang, Y | 1 |
| Gong, W | 1 |
| Ding, Y | 1 |
| Lu, G | 1 |
| Liu, W | 1 |
| Liao, L | 1 |
| Shi, H | 1 |
| Wu, B | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Camus, M | 1 |
| Khungar, V | 1 |
| Jensen, DM | 1 |
| Ohning, GV | 1 |
| Kovacs, TO | 1 |
| Jutabha, R | 1 |
| Ghassemi, KA | 1 |
| Machicado, GA | 1 |
| Dulai, GS | 1 |
| Hreinsson, JP | 1 |
| Gumundsson, S | 1 |
| Kalaitzakis, E | 1 |
| Björnsson, ES | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sclerotherapy With Polidocanol Foam in the Treatment of First, Second and Third-Grade Hemorrhoidal Disease in Patients With Liver Cirrhosis: A Prospective, Cohort Trial[NCT05807425] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | 2023-03-31 | Recruiting | ||
| Video Capsule Endoscopy for Lesion Localization and Diagnosis in Patients With Severe Hematochezia[NCT03616041] | 50 participants (Anticipated) | Observational | 2021-02-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for aspirin and Colitis, Ischemic
| Article | Year |
|---|---|
Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study.
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ischemic; Colon; Co | 2020 |
[An analysis of clinical characteristics and risk factors for ulceration in ischemic colitis].
Topics: Aged; Aspirin; Colitis, Ischemic; Constipation; Female; Gastrointestinal Hemorrhage; Hospitalization | 2014 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-C | 2013 |